Compounds > naltrexone

naltrexone and Allergic Encephalomyelitis

naltrexone has been researched along with Allergic Encephalomyelitis in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's6 (66.67)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Barrientos, RM; Clements, MA; Duran-Malle, JC; Harris, KM; Kwilasz, AJ; Larson, TA; Litwiler, ST; Maier, SF; Mitten, EH; Rice, KC; Schrama, AEW; Todd, LS; Van Dam, AM; Wang, X; Watkins, LR1
Ludwig, MD; McLaughlin, PJ; Zagon, IS2
McLaughlin, PJ; Zagon, IS1
Magister, MJ; McHugh, DP; McLaughlin, PJ; Zagon, IS1
Hammer, LA; McLaughlin, PJ; Waldner, H; Zagon, IS1
McLaughlin, PJ; Rahn, KA; Turel, AP; Zagon, IS1
McLaughlin, PJ; Rahn, KA; Zagon, IS1
Locatelli, L; Manfredi, B; Monastra, G; Panerai, AE; Radulovic, J; Sacerdote, P1

Reviews

1 review(s) available for naltrexone and Allergic Encephalomyelitis

ArticleYear
Intermittent blockade of OGFr and treatment of autoimmune disorders.
    Experimental biology and medicine (Maywood, N.J.), 2018, Volume: 243, Issue:17-18

    Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Humans; Mice; Multiple Sclerosis; Naltrexone; Narcotic Antagonists; Receptors, Opioid

2018

Other Studies

8 other study(ies) available for naltrexone and Allergic Encephalomyelitis

ArticleYear
Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2/TLR4 antagonist (+)-naltrexone.
    Behavioural brain research, 2021, 01-01, Volume: 396

    Topics: Animals; Behavior, Animal; Cells, Cultured; Conditioning, Classical; Encephalomyelitis, Autoimmune, Experimental; Fear; Hippocampus; Inflammation; Male; Memory Disorders; Mice; Microglia; Multiple Sclerosis; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Toll-Like Receptor 2; Toll-Like Receptor 4

2021
Featured Article: Serum [Met
    Experimental biology and medicine (Maywood, N.J.), 2017, Volume: 242, Issue:15

    Topics: Adult; Aged; Aged, 80 and over; Animals; Biomarkers; Encephalomyelitis, Autoimmune, Experimental; Enkephalin, Methionine; Female; Humans; Male; Mice, Inbred C57BL; Middle Aged; Multiple Sclerosis; Naltrexone; Neuroprotective Agents; Serum; Treatment Outcome; Volunteers; Young Adult

2017
Featured Article: Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Experimental biology and medicine (Maywood, N.J.), 2018, Volume: 243, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Animals; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Enkephalin, Methionine; Female; Glatiramer Acetate; Humans; Immunosuppressive Agents; Male; Mice, Inbred C57BL; Middle Aged; Multiple Sclerosis; Naltrexone; Receptors, Opioid

2018
Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
    BMC immunology, 2015, Apr-24, Volume: 16

    Topics: Analgesics, Opioid; Animals; B-Lymphocytes; Behavior, Animal; Cell Proliferation; Encephalomyelitis, Autoimmune, Experimental; Female; Immunization; Intracellular Space; Lymph Nodes; Lymphocyte Count; Lymphocyte Subsets; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Naltrexone; Spleen; T-Lymphocytes

2015
Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Experimental biology and medicine (Maywood, N.J.), 2016, Volume: 241, Issue:1

    Topics: Animals; CD4-Positive T-Lymphocytes; Central Nervous System; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enkephalin, Methionine; Female; Mice; Multiple Sclerosis; Naltrexone; Narcotic Antagonists

2016
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
    Experimental biology and medicine (Maywood, N.J.), 2009, Volume: 234, Issue:11

    Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Naltrexone; Nervous System

2009
Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.
    Brain research, 2011, Mar-24, Volume: 1381

    Topics: Analysis of Variance; Animals; Astrocytes; Chi-Square Distribution; Encephalomyelitis, Autoimmune, Experimental; Enkephalin, Methionine; Female; Mice; Mice, Inbred C57BL; Myelin Proteins; Myelin Sheath; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Naltrexone; Neurons

2011
Beta-endorphin concentrations in brain areas and peritoneal macrophages in rats susceptible and resistant to experimental allergic encephalomyelitis: a possible relationship between tumor necrosis factor alpha and opioids in the disease.
    Journal of neuroimmunology, 1994, Volume: 51, Issue:2

    Topics: Animals; beta-Endorphin; Brain Chemistry; Encephalomyelitis, Autoimmune, Experimental; Immunoglobulin G; Macrophages, Peritoneal; Male; Naltrexone; Rats; Rats, Inbred BN; Rats, Inbred Lew; Substance P; Tumor Necrosis Factor-alpha

1994